Effect of dose modifications on response to duvelisib in patients with relapsed/refractory (R/R) CLL/SLL in the DUO trial.

Ian Flinn, Marco Montillo, Arpad Illes, Gabriel Etienne, Julio Delgado, Bryone J Kuss, Constantine Si Lun Tam, Fritz Offner, Francesc Bosch, Matthew Steven Davids, Ulrich Jager, Paolo Ghia, Florence Cymbalista, David T Weaver, Stephanie Lustgarten, Hagop Youssoufian, Stephan Stilgenbauer, Nicole Lamanna